Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/41856
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPaton, A.-
dc.contributor.authorPaton, J.-
dc.contributor.authorBacker, M.-
dc.contributor.authorBacker, J.-
dc.date.issued2008-
dc.identifier.urihttp://hdl.handle.net/2440/41856-
dc.description.abstractCleavage of BIP (Immunoglobulin binding protein) by subtilase toxin and its application to inhibiting growth of or killing of cells. This has application to treatment of cancers and to conformational diseases and in particular to conformational diseases involving BiP that are influenced by cleavage by the subtilase cytotoxin. The invention also relates to subtilase toxin molecules specifically targeting proliferating cells, in particular tumor cells, or cells expressing a vascular endothelial growth factor receptor.-
dc.language.isoen-
dc.source.urihttp://www.wipo.int/pctdb/en/wo.jsp?ELEMENT_SET=F&LANGUAGE=ENG&KEY=08/014574&IA=08/014574&DISPLAY=STATUS-
dc.titleCleavage of BiP by Subtilase Cytotoxin-
dc.typePatent-
dc.contributor.organisationAdelaide Research & Innovation Pty Ltd-
dc.contributor.assigneeAdelaide Research & Innovation-
dc.identifier.patentInt App No: PCT/AU2007/001111-
pubs.publication-statusPublished-
dc.identifier.orcidPaton, J. [0000-0001-9807-5278]-
Appears in Collections:Aurora harvest 6
Microbiology and Immunology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.